Shirakawa Hisashi, Katsumoto Rumi, Iida Shota, Miyake Takahito, Higuchi Takuya, Nagashima Takuya, Nagayasu Kazuki, Nakagawa Takayuki, Kaneko Shuji
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, 606-8507, Japan.
Glia. 2017 Jun;65(6):1005-1016. doi: 10.1002/glia.23141. Epub 2017 Mar 16.
A biologically active lipid, sphingosine-1-phosphate (S1P) is highly abundant in blood, and plays an important role in regulating the growth, survival, and migration of many cells. Binding of the endogenous ligand S1P results in activation of various signaling pathways via G protein-coupled receptors, some of which generates Ca mobilization. In astrocytes, S1P is reported to evoke Ca signaling, proliferation, and migration; however, the precise mechanisms underlying such responses in astrocytes remain to be elucidated. Transient receptor potential canonical (TRPC) channels are Ca -permeable cation channels expressed in astrocytes and involved in Ca influx after receptor stimulation. In this study, we investigated the involvement of TRPC channels in S1P-induced cellular responses. In Ca imaging experiments, S1P at 1 μM elicited a transient increase in intracellular Ca in astrocytes, followed by sustained elevation. The sustained Ca response was markedly suppressed by S1P receptor antagonist JTE013, S1P receptor antagonist CAY10444, or non-selective TRPC channel inhibitor Pyr2. Additionally, S1P increased chemokine CXCL1 mRNA expression and release, which were suppressed by TRPC inhibitor, inhibition of Ca mobilization, MAPK pathway inhibitors, or knockdown of the TRPC channel isoform TRPC6. Taken together, these results demonstrate that S1P induces Ca signaling in astrocytes via G -coupled receptors S1P and S1P , followed by Ca influx through TRPC6 that could activate MAPK signaling, which leads to increased secretion of the proinflammatory or neuroprotective chemokine CXCL1.
生物活性脂质鞘氨醇-1-磷酸(S1P)在血液中含量极高,在调节多种细胞的生长、存活和迁移中发挥重要作用。内源性配体S1P的结合通过G蛋白偶联受体激活各种信号通路,其中一些会引发钙动员。据报道,在星形胶质细胞中,S1P可引发钙信号、增殖和迁移;然而,星形胶质细胞中此类反应的精确机制仍有待阐明。瞬时受体电位经典型(TRPC)通道是在星形胶质细胞中表达的钙通透性阳离子通道,参与受体刺激后的钙内流。在本研究中,我们调查了TRPC通道在S1P诱导的细胞反应中的作用。在钙成像实验中,1μM的S1P引起星形胶质细胞内钙的瞬时增加,随后持续升高。S1P受体拮抗剂JTE013、S1P受体拮抗剂CAY10444或非选择性TRPC通道抑制剂Pyr2可显著抑制这种持续的钙反应。此外,S1P增加趋化因子CXCL1 mRNA的表达和释放,而TRPC抑制剂、钙动员抑制、MAPK途径抑制剂或TRPC通道亚型TRPC6的敲低可抑制这种增加。综上所述,这些结果表明,S1P通过G偶联受体S1P和S1P在星形胶质细胞中诱导钙信号,随后通过TRPC6引起钙内流,这可能激活MAPK信号,从而导致促炎或神经保护趋化因子CXCL1的分泌增加。